Literature DB >> 19766167

Antibody binding to cell surface amyloid precursor protein induces neuronal injury by deregulating the phosphorylation of focal adhesion signaling related proteins.

Yu-Xia Xu1, Hong-Quan Wang, Jie Yan, Xiao-Bo Sun, Jing-Chun Guo, Cui-Qing Zhu.   

Abstract

The biological function of full-length amyloid-beta protein precursor (APP), the precursor of Abeta, is not fully understood. Mounting studies reported that antibody binding to cell surface APP causes neuronal injury. However, the mechanism of cell surface APP mediating neuronal injury remains to be determined. Colocalization of APP with integrin on cell surface leads us to suppose that focal adhesion (FA) related mechanism is involved in surface APP-mediated neuronal injury. In the present study, results demonstrated that primary cultured neurons treated with antibody against APP-N-terminal not only caused neuronal injury and aberrant morphologic changes of neurite, but also induced reaction of FA proteins appearing an acute increase then decrease pattern. Moreover, the elevation of tyrosine phosphorylation of FA proteins including paxillin and focal adhesion kinase (FAK), and down-regulated expression of protein tyrosine phosphatase (PTP1B) induced by APP antibody were prevented by inhibitor of Src protein kinases 4-amino-5-(4-chlorophenyl)-7(t-butyl) pyrazol (3,4-D) pyramide (PP2) and G protein inhibitor pertussis toxin (PTX), implying that Src family kinase and G protein play roles in APP-induced FA signals. In addition, pretreatment with PTX and PP2 was able to suppress APP-antibody induced neuronal injury. Taken together, the results suggest a novel mechanism for APP mediating neuronal injury through deregulating FA signals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19766167     DOI: 10.1016/j.neulet.2009.09.022

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

Review 1.  Role of APP Interactions with Heterotrimeric G Proteins: Physiological Functions and Pathological Consequences.

Authors:  Philip F Copenhaver; Donat Kögel
Journal:  Front Mol Neurosci       Date:  2017-01-31       Impact factor: 5.639

2.  Glutamate enhances the surface distribution and release of Munc18 in cerebral cortical neurons.

Authors:  Ping Wan; Yan-Ping Zhang; Jie Yan; Yu-Xia Xu; Hong-Quan Wang; Ru Yang; Cui-Qing Zhu
Journal:  Neurosci Bull       Date:  2010-08       Impact factor: 5.203

3.  PTEN, a widely known negative regulator of insulin/PI3K signaling, positively regulates neuronal insulin resistance.

Authors:  Amit Gupta; Chinmoy Sankar Dey
Journal:  Mol Biol Cell       Date:  2012-08-08       Impact factor: 4.138

4.  PAT1 inversely regulates the surface Amyloid Precursor Protein level in mouse primary neurons.

Authors:  Aysegul Dilsizoglu Senol; Lidia Tagliafierro; Léa Huguet; Lucie Gorisse-Hussonnois; Stéphanie Chasseigneaux; Bernadette Allinquant
Journal:  BMC Neurosci       Date:  2015-03-07       Impact factor: 3.288

Review 5.  The new genetic landscape of Alzheimer's disease: from amyloid cascade to genetically driven synaptic failure hypothesis?

Authors:  Pierre Dourlen; Devrim Kilinc; Nicolas Malmanche; Julien Chapuis; Jean-Charles Lambert
Journal:  Acta Neuropathol       Date:  2019-04-13       Impact factor: 17.088

Review 6.  Glaucoma as Neurodegeneration in the Brain.

Authors:  Jane W Chan; Noel C Y Chan; Alfredo A Sadun
Journal:  Eye Brain       Date:  2021-01-18

7.  FAK-Mediated Signaling Controls Amyloid Beta Overload, Learning and Memory Deficits in a Mouse Model of Alzheimer's Disease.

Authors:  Bisan Saleh; Kolluru D Srikanth; Tal Sneh; Lambert Yue; Steven Pelech; Evan Elliott; Hava Gil-Henn
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

8.  Immunotherapy by targeting of VGKC complex for seizure control and prevention of cognitive impairment in a mouse model of epilepsy.

Authors:  Zhiliang Fan; Xiaojuan Feng; Zhigang Fan; Xingyuan Zhu; Shaohua Yin
Journal:  Mol Med Rep       Date:  2018-05-09       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.